The history of the erectile dysfunction drug presents a challenging picture for investors. While the initial launch generated substantial gains, the lapse of its patent opened the avenue to cheaper alternatives, https://bookmarkja.com/story24492140/viagra-and-pharma-a-risky-opportunity